Straumann Holding AG (STMN)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Straumann Holding AG (STMN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011974
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:71
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Straumann Holding AG (Straumann) develops dental implants and devices. Straumann’s product portfolio includes dental implants, active surfaces, prosthetic components, digital solutions such as intra-oral scanning, and CADCAM, bone substitutes, and regenerative membranes. The company categorizes its solutions under three groups: tooth replacement solutions, restorative solutions and regenerative solutions. Its products find applications in tooth replacement and restoration solutions or prevention of tooth loss. It also offers a wide range of customized services including practice building tools, business building initiatives, customer hotline. The company markets and sells its solutions and services directly to dental professionals through its subsidiaries and distribution partners in Europe, North America, Asia-Pacific and other regions throughout the world. Straumann is headquartered in Basel, Switzerland.

Straumann Holding AG (STMN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Straumann Holding AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Straumann Holding AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Straumann Holding AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Straumann Holding AG, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Straumann Holding AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Straumann Holding AG, Medical Equipment, Deal Details 12
Partnerships 12
RODO Medical Enters into Agreement with Straumann 12
Straumann and Maxon Motor to Form Joint Venture 13
Straumann Enters into Distribution Agreement with botiss dental 14
Dental Wings, 3M ESPE Enters Into Agreement With Straumann 15
Straumann Holding Signs North American Distribution Agreement With Cadent 16
Debt Offering 17
Megagen Announces Private Placement Of Bonds For US$30 Million 17
Acquisition 18
Straumann to Acquire ClearCorrect for USD150 Million 18
Straumann to Acquire 38% Stake in Geniova 19
Straumann to Acquire Remaining 45% Stake in Dental Wings 20
Straumann Acquires Additional 18% Stake in RODO Medical 21
Straumann Holding to Acquire Remaining 49% Stake in Medentika 22
Straumann to Acquire Equinox Medical Benelux 23
Straumann to Acquire Controlling Stake in MegaGen 24
Straumann to Acquire 30% Stake in Anthogyr 25
Straumann Acquires Additional 9% Stake in Dental Wings 26
Straumann to Acquire Remaining 51% Stake in Neodent for USD218 Million 27
Straumann Acquires 44% Stake in Valoc 28
Straumann Acquires 12% Stake in RODO Medical 29
Straumann Acquires 51% Stake in Medentik for USD44 Million 30
Straumann Acquires 30% Stake in Createch Medical 31
GIC Acquires 10% Stake In Straumann 32
Straumann Acquires 49% Stake In Neodent, Dental Implant Company, For US$277.3 Million 34
Straumann Acquires 30% Stake In Dental Wings 36
Straumann Holding AG – Key Competitors 37
Straumann Holding AG – Key Employees 38
Straumann Holding AG – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Affiliate 41
Recent Developments 42
Strategy And Business Planning 42
Feb 25, 2016: Straumann And Anthogyr Announce Partnership 42
Financial Announcements 43
Aug 17, 2017: Straumann Group posts H1 revenue growth of 14% with further margin improvement 43
Apr 27, 2017: Strong performance continues as Straumann posts 15% organic growth in Q1 47
Oct 27, 2016: Another Strong Quarter (+13% Organic) Keeps Straumann On Track To Achieve Full-Year Targets 50
Aug 23, 2016: Strong Performance Continues As Organic Growth Of 14% Lifts First-Half Revenue To Record Level 53
Aug 23, 2016: Straumann reports strong performance continues as organic growth of 14% lifts first-half revenue to record level 57
May 03, 2016: Straumann reports strong start to the year with organic revenue growth of 12% in Q1 61
Corporate Communications 63
Mar 20, 2017: Straumann Group strengthens executive team to sustain dynamic growth in APAC and to lead Global People Management & Development 63
May 23, 2016: Straumann Announces Change In Board Of Directors And Compensation Committee 64
Product News 65
Mar 22, 2017: Straumann Group presents numerous innovations at the 37th International Dental Show in Cologne 65
Other Significant Developments 69
Mar 08, 2017: Straumann complements its all-in-one solutions with 3Shape scanners and Rapid Shape 3D printers 69
Jul 18, 2016: Straumann takes over distribution of botiss products in Germany 70
Appendix 71
Methodology 71
About GlobalData 71
Contact Us 71
Disclaimer 71

List of Tables
Straumann Holding AG, Medical Equipment, Key Facts, 2016 2
Straumann Holding AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Straumann Holding AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Straumann Holding AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Straumann Holding AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Straumann Holding AG, Deals By Market, 2011 to YTD 2017 9
Straumann Holding AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
RODO Medical Enters into Agreement with Straumann 12
Straumann and Maxon Motor to Form Joint Venture 13
Straumann Enters into Distribution Agreement with botiss dental 14
Dental Wings, 3M ESPE Enters Into Agreement With Straumann 15
Straumann Holding Signs North American Distribution Agreement With Cadent 16
Megagen Announces Private Placement Of Bonds For US$30 Million 17
Straumann to Acquire ClearCorrect for USD150 Million 18
Straumann to Acquire 38% Stake in Geniova 19
Straumann to Acquire Remaining 45% Stake in Dental Wings 20
Straumann Acquires Additional 18% Stake in RODO Medical 21
Straumann Holding to Acquire Remaining 49% Stake in Medentika 22
Straumann to Acquire Equinox Medical Benelux 23
Straumann to Acquire Controlling Stake in MegaGen 24
Straumann to Acquire 30% Stake in Anthogyr 25
Straumann Acquires Additional 9% Stake in Dental Wings 26
Straumann to Acquire Remaining 51% Stake in Neodent for USD218 Million 27
Straumann Acquires 44% Stake in Valoc 28
Straumann Acquires 12% Stake in RODO Medical 29
Straumann Acquires 51% Stake in Medentik for USD44 Million 30
Straumann Acquires 30% Stake in Createch Medical 31
GIC Acquires 10% Stake In Straumann 32
Straumann Acquires 49% Stake In Neodent, Dental Implant Company, For US$277.3 Million 34
Straumann Acquires 30% Stake In Dental Wings 36
Straumann Holding AG, Key Competitors 37
Straumann Holding AG, Key Employees 38
Straumann Holding AG, Subsidiaries 39
Straumann Holding AG, Affiliate 41

★海外企業調査レポート[Straumann Holding AG (STMN)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Anergis SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Anergis SA (Anergis) is a clinical stage biopharmaceutical company that discovers, develops and markets immunotherapy products. The company uses synthetic, pharmaceutical-grade contiguous overlapping peptide to derive allergy immunotherapeutics from its proprietary long peptide technology pl …
  • Central Bank Of India:企業の戦略・SWOT・財務分析
    Central Bank Of India - Strategy, SWOT and Corporate Finance Report Summary Central Bank Of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ThyssenKrupp AG:企業の戦略・SWOT・財務情報
    ThyssenKrupp AG - Strategy, SWOT and Corporate Finance Report Summary ThyssenKrupp AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Johnson Electric Holdings Limited:企業の戦略・SWOT・財務情報
    Johnson Electric Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Johnson Electric Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • permanent tsb Group Holdings p.l.c.:企業の戦略・SWOT・財務情報
    permanent tsb Group Holdings p.l.c. - Strategy, SWOT and Corporate Finance Report Summary permanent tsb Group Holdings p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • WSI Industries, Inc.:企業の戦略・SWOT・財務分析
    WSI Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary WSI Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Union Bank of Taiwan:企業の戦略・SWOT・財務情報
    Union Bank of Taiwan - Strategy, SWOT and Corporate Finance Report Summary Union Bank of Taiwan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Program for Appropriate Technology in Health:医療機器:M&Aディール及び事業提携情報
    Summary Program for Appropriate Technology in Health (PATH) is a non-profit organization that improves health in women and children. The organization offers vaccines, drugs, diagnostics, devices, system and service innovations, and digital health solutions. It develops diagnostics for HIV and other …
  • Karyopharm Therapeutics Inc (KPTI):企業の財務・戦略的SWOT分析
    Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Tasly Pharmaceutical Group Co Ltd (600535):企業の財務・戦略的SWOT分析
    Tasly Pharmaceutical Group Co Ltd (600535) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Anthem Inc (ANTM):企業の財務・戦略的SWOT分析
    Anthem Inc (ANTM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Citigroup Inc:企業の戦略・SWOT・財務情報
    Citigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Citigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Relisys Medical Devices Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Relisys Medical Devices Ltd (Relisys), formerly Care Polymed Ltd is a medical device company that develops, manufactures and commercializes catheter products. The company’s products include drug eluting stent systems, bare metal stent systems, PTCA catheters and angiographic catheters. Its a …
  • Shimizu Corporation:企業の戦略・SWOT・財務分析
    Shimizu Corporation - Strategy, SWOT and Corporate Finance Report Summary Shimizu Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • TAXIS Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary TAXIS Pharmaceuticals Inc (TAXIS Pharma) is a biopharmaceutical company that treats, reduce and eliminates the threat of current and emergent antimicrobial resistance across a range of infectious diseases. It research new classes of antibiotic agents to treat life-threatening and multidrug-r …
  • DNO ASA (DNO):企業の財務・戦略的SWOT分析
    Summary DNO ASA (DNO) is an oil and gas company that provides mineral properties exploration and development services. The company's services include selective and targeted drilling, fractured carbonate plays that are characteristic of the MENA region. It operates its oil and gas producing assets lo …
  • Chubu Electric Power Co Inc (9502):電力:M&Aディール及び事業提携情報
    Summary Chubu Electric Power Co Inc (Chubu) is an energy utility. It generates and procures electricity; and offers electric network related services. The company produces electricity using hydro, thermal, nuclear and renewable sources. Chubu has interests in upstream and midstream energy fields. It …
  • BioMarin Pharmaceutical Inc (BMRN):企業の財務・戦略的SWOT分析
    BioMarin Pharmaceutical Inc (BMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Delegat’s Group Limited:企業の戦略・SWOT・財務分析
    Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report Summary Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • 4SC AG (VSC):製薬・医療:M&Aディール及び事業提携情報
    Summary 4SC AG (4SC) is a biopharmaceutical company that discovers and develops small molecule drugs for the treatment of cancer and autoimmune diseases. The company’s product focuses on epigenetics, cancer stem cells and cancer immunotherapy. Its product pipeline comprises therapeutic programs at v …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆